University hospital Nancy
Welcome,         Profile    Billing    Logout  
 17 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BERGER, Eric
TOTEM-RRMS, NCT03910738: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Recruiting
2
40
Europe
Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection, Placebo 4 mL Solution for Injection, MRI, Assessment of impact of MS on cognition; quality of life; fatigue; anxiety/depression and work and activities, Assessment of disability
University Hospital, Strasbourg, France, Bayer, Fédération Hospitalo-Universitaire NEUROGENYCS, Grünenthal GmbH
Multiple Sclerosis, Relapsing-Remitting
01/27
01/27
WORKSEP, NCT04860791: Validation of the French Adaptation of the MSWDQ-23 Questionnaire

Completed
N/A
206
Europe
questionnaires
Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
05/23
05/23
BABYZUMAB-2, NCT05209815: Safety of Exposure to Natalizumab During Pregnancy

Completed
N/A
68
Europe, RoW
Questionnaire
University Hospital, Bordeaux, Biogen
Multiple Sclerosis
12/23
12/23
NeurofilMS, NCT03981003: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Recruiting
N/A
1150
Europe, RoW
Blood sample
Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon
Multiple Sclerosis
06/28
06/28
RESPONSE, NCT03900221: French Registry for Monitoring Pregnancies for Multiple Sclerosis

Recruiting
N/A
1000
Europe, RoW
No intervention
Hospices Civils de Lyon
Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal
08/36
08/36
Sèze, Jérôme de
OPTIS, NCT05566769: Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Recruiting
N/A
103
Europe, US
NMOSDCopilot smartphone application
Ad scientiam
Neuromyelitis Optica
04/25
04/26
Debouverie, Marc MD
BABYZUMAB-2, NCT05209815: Safety of Exposure to Natalizumab During Pregnancy

Completed
N/A
68
Europe, RoW
Questionnaire
University Hospital, Bordeaux, Biogen
Multiple Sclerosis
12/23
12/23
VHD cohort, NCT05622643: OFSEP Very High Definition Cohort

Recruiting
N/A
300
Europe
MRI
EDMUS Foundation
Multiple Sclerosis
01/26
01/27
NeurofilMS, NCT03981003: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

Recruiting
N/A
1150
Europe, RoW
Blood sample
Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon
Multiple Sclerosis
06/28
06/28
RESPONSE, NCT03900221: French Registry for Monitoring Pregnancies for Multiple Sclerosis

Recruiting
N/A
1000
Europe, RoW
No intervention
Hospices Civils de Lyon
Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal
08/36
08/36
INESEP, NCT05017038: The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple Sclerosis

Recruiting
N/A
2000
Europe
Central Hospital, Nancy, France
Multiple Sclerosis, Social and Territorial Inequalities
03/23
06/23
Lemelle, Irène
MYOCIT, NCT05524311 / 2022-000506-10: Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis

Recruiting
2
16
Europe
Baricitinib, pharmacokinetics study, dosage of cytokines, transcriptomic analysis, Parent version of the Child Health Questionnaire (CHQ), Childhood Health Assessment Questionnaire, Pregnancy test
Assistance Publique - Hôpitaux de Paris, DGOS
Juvenile Dermatomyositis
05/26
09/26
JSSc, NCT06019234: Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort

Recruiting
N/A
30
Europe
University Hospital, Strasbourg, France
Juvenile Systemic Sclerosis
10/24
10/24

Download Options